The Medical Science Liaison: An A to Z Guide, Second Edition

Оглавление

Erin Ph.D. Albert. The Medical Science Liaison: An A to Z Guide, Second Edition

Introduction: The History of the MSL

The Past and Future of MSLs: Interview with Stan Bernard, MD, MBA

History

PART I: BECOMING A MSL. Chapter 1: What is a MSL?

The Challenges of a MSL

The Real World: An Interview with a Working MSL - Ernie Pitting, RPh, MS, PharmD candidate

Chapter 2: Activities, Salary, Job Satisfaction and Career Paths of the MSL

Benefits for the MSL: Interview with Chris Conley, CSAM

Chapter 3: Getting Hired

Part 1: Values Assessment

Skills and abilities specific to the MSL:

Part 2: Resume/CV

Part 3: The Cover Letter

Contacts/Networking Strategies

Getting Into the MSL Role: A Recruiter’s Perspective - Interview with Tony Beachler

PART II: PERFECTING THE ART OF LIAISING. Chapter 4: Starting off as a MSL

Miscellaneous for the New MSL

Erin’s List of Over 20 places to find Thought Leaders

Regulatory Compliance

Legal/Regulatory Issues for the MSL To Consider: Interview with Christopher R. Hall, Esq

The International MSL Perspective: Interview with Michael Hamann, PhD

Chapter 5: Customers’ Viewpoints

Interview with Chris Bojrab, MD

Interview with Ron Chervin, MD, MS

Interview with James A. Simon, MD, CCD, FACOG

Interview with Paul Keck, MD

Chapter 6: Research & Technology

Resources For the MSL: An Interview with LouAnn Fare, MS

Managing Medical Information: An Interview with Dr. Amy Peak

MSLs, Metrics and Technology

About Metrics: An Interview with Michael Taylor

Chapter 7: Work + Life = Balance?

Erin’s Wall of Fame

The MSL Father - Tim Hill, PharmD, MS

Working as a MSL/Mom: Interview with Carole Carter-Olkowski

Working Solo - It’s Really A Team Effort

PART III: POST MSL - WHAT’S NEXT? Chapter 8: Job Hopping

The MSL Moving Onward: Interview with Bryan Vaughn

Over 30 Things To Have Experienced By Your 5th Year as a MSL:

Chapter 9: Management of MSLs

Medical Science Liaison Outsourcing: Interview with Kyle Kennedy

Interview with a MSL Manager: Susan E. Malecha, PharmD, MBA

Chapter 10: The Afterlife

Other career alternatives for MSLs:

Academic Pharmacy After the MSL role: Interview with Scott Stolte, PharmD

Entrepreneurialism Post MSL: Interview with Jane Chin, PhD

Ten Transferable Skills From MSL to Entrepreneur:

Life After the MSL Role in Medical Education: Interview with Matt Lewis, MPA

Chapter 11: The Future of the MSL Role

The Clinical Trial Liaison: Interview with Brian Best

Future Of The MSL: Closing Interview with Dr. Stan Bernard

In Conclusion

Appendix A: Major Medical Associations/Meetings for Therapeutic Areas

Appendix B: Real World Career Paths to and Beyond the MSL

Appendix C: Acronyms & Abbreviations

Bibliography, References, and Resources

Acknowledgements

PART IV: SECOND EDITION NEW MATERIAL. Epilogue (Second Edition Bonus Material)

New Interviews: What is Beyond the MSL Role?

Anonymous

Charles Arena, MD Medical Director, Utah Clinical Trials, LLC

Tom Peddicord, PharmD, FCCP Account Group Director, Global Prairie

Updates Since the First Edition

Other Books By Dr. Erin Albert

Отрывок из книги

Many know that the origin of the Medical Science Liaison (MSL) came out of Upjohn. What is not largely known, however, is the drug that started the MSL movement: it was tolbutamide (Orinase®). According to the text, A Century of Caring: The Upjohn Story by Robert Carlisle, the first ever MSL program was initiated by marketing to establish rapport and provide educational awareness to doctors before they were able to write prescriptions, during medical school. In 1967, the program was started and seeded by sales professionals that had, “intense interest in science, [had] high social skills, and recognize[d] that they [were] no longer detailing products”.1

The MSLs began calling on medical schools and thus, a movement was born. Upjohn had been mostly unknown to medical students, but after just 6 years of the MSL program, “Upjohn was one of the best-known”1 companies to medical students. The entire onus of the MSL was to provide education in the form of monographs, access to internal researchers, and assistance for external educational programs. The program was conceptualized and developed a mission to provide appropriate use of oral diabetic drugs, which at the time was a novel approach to diabetes.1

.....

From the outset, MSMs were designed to be different from MSLs and other sales representatives. As doctors, MSMs could relate to and interact with key opinion leaders and other doctors as “peers”. They shared a comparable level of scientific training, experiences, and knowledge with their physician customers. This enabled MSMs to earn the respect and time of physicians. In fact, BMS marketers found that MSMs were spending dramatically more time with physicians than sales representatives.

The roles of MSMs also differed dramatically from those of MSLs. We trained MSMs to handle several novel tasks, such as the management of regional and local opinion leaders, including speaker training; identification and placement of Phase IIIB and IV clinical trials; facilitation of physician dinner meetings; spearheading the pre-launch of new products; and training of sales representatives on disease states and product information. Like a special military force, the roles of MSMs expanded over time as senior Bristol-Myers Squibb (“BMS”) executives recognized their extensive capabilities and impact.

.....